Advertisement

Topics

New Data Indicates Use of Baxter’s FLOSEAL in Cardiac and Spinal Surgeries May Be Associated with Lower Hospital Costs

08:05 EDT 14 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Two new economic analyses quantify findings of previously published retrospective studies that observed improved clinical outcomes associated with FLOSEAL use compared to another flowable hemostatic matrix ...

Other Sources for this Article

Baxter International Inc.
Media Contact
Beth Mueller, (224) 948-5353
media@baxter.com
or
Investor Contact
Clare Trachtman, (224) 948-3085

NEXT ARTICLE

More From BioPortfolio on "New Data Indicates Use of Baxter’s FLOSEAL in Cardiac and Spinal Surgeries May Be Associated with Lower Hospital Costs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...